Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.
about
Targeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsResearch Progression of Maintenance Therapy in Small Cell Lung CancerGenomic profiling of small-cell lung cancer: the era of targeted therapiesTargeting angiogenesis in small cell lung cancerTreatment options for small cell lung cancer - do we have more choice?Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer.Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer.Targeted therapies in small cell lung cancer: a reviewImmunotherapy treatments for small-cell lung cancer: past, present and future.Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer.Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinomaTargeted therapies in small cell lung cancerSmall Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?The development of targeted therapy in small cell lung cancer.NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.Research progress in the treatment of small cell lung cancer.Update on new drugs in small cell lung cancer.Advances in pharmacotherapy of small cell lung cancer.A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.Expression of c-Kit and PDGFRα in epithelial ovarian tumors and tumor stroma.Coexistence of gastrointestinal stromal tumors and gastric adenocarcinomas.A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients.
P2860
Q26767017-FF35723B-B8A9-44BA-9874-81AE8F113943Q26767020-01168D49-B792-489E-A081-52730DFFA997Q26783450-31BFE4FB-2B98-49EA-AA38-68008E7C2E76Q26826915-1597536D-6EB9-45C0-89D6-F156BB8D3DDCQ28068385-AEC46DED-52BA-4A2E-BFDC-9F9FFA5E2EE4Q33723735-D537E418-3B8F-4CB1-B58A-BB5AACED38ADQ33843815-4991D51E-41C5-407F-AB17-A67FEA76A4BDQ34013850-FEDC4337-F41A-4589-B028-AEEDFA39C033Q35076234-0CD7181D-4692-4AE2-8F8C-2B54F0DA993CQ35904003-6FF24247-B284-4898-9387-06665049A3FFQ36099315-2BF7780B-ADAD-40C2-BD2F-4191DD94BF07Q36240984-93DF492D-6C3E-481B-904E-ABDED5B82DD6Q36475811-4315B0FB-53BC-41AE-9F0E-D32C6DC8FAB9Q36811784-B09F56CE-3EB7-4E00-8DC5-6EED610E45EDQ37127932-F5BDA35B-EDF7-41FE-8BAC-2B798130119FQ37590339-D411CA1B-14C0-4CEB-88B5-C68A08214DBCQ37604301-58ED3B24-44DD-485D-9EBD-EE5EAD9BAA95Q37851992-EA95A26E-E612-4A04-83BC-ED6DE00E03BBQ38254295-17BD10C9-6DBB-451D-BF7D-FEEE0CDD2A61Q40059049-545E47D0-28D4-4CE5-B688-CB19F4450ED2Q42180765-9A73F75E-4F65-4FA6-BA42-073A7C4A33D0Q43717477-E3D262C7-9F90-4C1D-BE20-29F9B7B1CB57Q47140337-BACFAE14-D97F-4521-BDAE-A2FDB31D6B6B
P2860
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@ast
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@en
type
label
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@ast
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@en
prefLabel
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@ast
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@en
P2093
P356
P1433
P1476
Phase II trial of imatinib mai ...... -stage small-cell lung cancer.
@en
P2093
Antoinette J Wozniak
Bryan J Schneider
Francis P Worden
Gregory P Kalemkerian
Michael J Kraut
Nithya Ramnath
Shirish M Gadgeel
Xiaohui Zhang
P304
P356
10.3816/CLC.2010.N.028
P407
P577
2010-07-01T00:00:00Z